MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jaci.2023.07.005

Медицинская библиотека · The Journal of allergy and clinical immunology · 2023

Single-cell profiling of prurigo nodularis demonstrates immune-stromal crosstalk driving profibrotic responses and reversal with nemolizumab.

Ma Feiyang, Gharaee-Kermani Mehrnaz, Tsoi Lam C, Plazyo Olesya, Chaskar Prasad, Harms Paul, Patrick Matthew T, Xing Xianying, Hile Grace, Piketty Christophe, Lazzari Anne, Van Delm Wouter, Maverakis Emanual, Nakamura Mio, Modlin Robert L, Kahlenberg J Michelle, Billi Allison C, Julia Valerie, Krishnaswamy Jayendra Kumar, Gudjonsson Johann E

СтатьяПоддержка исследования: вне правительства СШАПоддержка NIH: внешняя программаПеревод в очереди

Аннотация

BACKGROUND

Prurigo nodularis (PN) is a chronic neuroimmune skin disease characterized by bilaterally distributed pruritic hyperkeratotic nodules on extremities and trunk. Neuroimmune dysregulation and chronic scratching are believed to both induce and maintain the characteristic lesions.

OBJECTIVES

This study sought to provide a comprehensive view of the molecular pathogenesis of PN at the single-cell level to identify and outline key pathologic processes and the cell types involved. Features that distinguish PN skin from the skin of patients with atopic dermatitis were of particular interest. We further aimed to determine the impact of the IL31RA antagonist, nemolizumab, and its specificity at the single-cell level.

METHODS

Single-cell RNA-sequencing of skin from 15 healthy donors and nonlesional and lesional skin from 6 patients each with PN and atopic dermatitis, combined with spatial-sequencing using the 10x Visium platform. Integration with bulk RNA-sequencing data from patients treated with nemolizumab.

RESULTS

This study demonstrates that PN is an inflammatory skin disease characterized by both keratinocyte proliferation and activation of profibrotic responses. This study also demonstrates that the COL11A1+ fibroblast subset is a major contributor to fibrosis and is predominantly found in the papillary dermis of PN skin. Activation of fibrotic responses is the main distinguishing feature between PN and atopic dermatitis skin. This study further shows the broad effect of nemolizumab on PN cell types, with a prominent effect driving COL11A1+ fibroblast and keratinocyte responses toward normal.

CONCLUSIONS

This study provides a high-resolution characterization of the cell types and cellular processes activated in PN skin, establishing PN as a chronic fibrotic inflammatory skin disease. It further demonstrates the broad effect of nemolizumab on pathological processes in PN skin.

Для цитирования: Ma Feiyang, Gharaee-Kermani Mehrnaz, Tsoi Lam C, Plazyo Olesya, Chaskar Prasad, Harms Paul, Patrick Matthew T, Xing Xianying, Hile Grace, Piketty Christophe, Lazzari Anne, Van Delm Wouter, Maverakis Emanual, Nakamura Mio, Modlin Robert L, Kahlenberg J Michelle, Billi Allison C, Julia Valerie, Krishnaswamy Jayendra Kumar, Gudjonsson Johann E. Single-cell profiling of prurigo nodularis demonstrates immune-stromal crosstalk driving profibrotic responses and reversal with nemolizumab.. The Journal of allergy and clinical immunology. 2023. DOI: 10.1016/j.jaci.2023.07.005.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.